Skip to content

Research on the Characteristics and Changes of Elderly Weakness in Shaanxi Region and Control Technologies

Research on the Characteristics and Changes of Elderly Weakness in Shaanxi Region and Control Technologies

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126633
Enrollment
Unknown
Registered
2026-06-12
Start date
2025-09-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty syndrome in the elderly

Interventions

The pre-frail elderly experimental group:Nutrition and exercise combined intervention
The pre-frail elderly control group:No interference
The frail elderly experimental group:Nutrition and exercise combined intervention
The frail elderly control group:No interference

Sponsors

The First Affiliated Hospital of PLA Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. over 65 years old; 2. Meet the following criteria: a. self-care or basic self-care; b. Basically normal cognitive function; 3. agree to participate in the study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Major cardiovascular and cerebrovascular events (including myocardial infarction, angina, and stroke) occurred in the past 3 months Middle and arterial revascularization); 2. patients with heart failure and lower cardiac function than class II; 3. patients with malignant tumors; 4. inability to cooperate with treatment and follow-up; 5. participating in other clinical trials; 6. patients who could not tolerate the study drug or used the intervention drug within 3 months; 7. Participants who were considered not to be included by the investigators.

Design outcomes

Primary

MeasureTime frame
Interleukin 6;

Secondary

MeasureTime frame
Aging damage markers (8-oxoGsn, SIRT1, SIRT3);Aging-regulated growth factors(IGF-1,FGF21,GDF15,GDF5,GDF8/MSTN);Inflammatory cytokines(TNF-a,CRP,IL-6);Hormone-related indicators(leptin,Cortisol, Dehydroepiandrosterone (DHEA));Routine inspection(Routine blood test, blood biochemical indexes);Fecal metagenomic testing;

Countries

China

Contacts

Public ContactWang Xiaoming

The First Affiliated Hospital of PLA Air Force Medical University

xmwang@fmmu.edu.cn+86 139 0928 1688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026